何氏眼科：公司正在推进收购的海外医道医疗株式会社，已布局干细胞外泌体相关研究

Core Viewpoint - He Eye Hospital is advancing in the field of gene therapy, focusing on hereditary eye diseases and offering a range of services including genetic testing and personalized risk screening [2] Group 1: Gene Therapy Initiatives - He Eye Hospital, led by renowned expert Professor Pang Jijing, has established a specialized clinic for hereditary eye diseases [2] - The clinic provides services such as genetic testing, diagnosis, treatment, personalized risk screening, and health management for hereditary eye disease patients and their families [2] Group 2: Business Developments - The company is progressing with the acquisition of overseas Medial Corporation, which is involved in stem cell exosome research [2] - The business scope of the acquisition includes the development of anti-aging products [2] - Current developments have not significantly impacted the company's main business operations or performance [2]